Neurocircuitries and neurotransmitter interactions in schizophrenia

International Clinical Psychopharmacology

Volumn 10, Issue , 1995, Pages 21-28

  Carlsson, A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Animal models; Dopamine; Glutamate; Neurocircuitries; Neurotransmitter interactions; Psychotogenesis; Schizophrenia; Thalamic filter

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; DOPAMINE; GLUTAMIC ACID; NORADRENALIN; SEROTONIN;

AGED; AROUSAL; CONFERENCE PAPER; CORPUS STRIATUM; HUMAN; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SCHIZOPHRENIA;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; NEUROTRANSMITTER AGENTS; SCHIZOPHRENIA;

EID: 0029583266     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/00004850-199509000-00004     Document Type: Article

References (42)

1. Alexander GE and Crutcher MD (1990) Functional architecture of basal ganglia circuíts: neural substrates of parallel processing. Trends in Neuroscience 13, 266–271.
2. Alheid G, Heimer L and Switzer RC (1990) The basal ganglia. In: The Human Nervous System. (Ed. G Paxinos). Academic Press, San Diego, pp, 483–582.
3. Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia (with commentaries and author’s reply). Neuropsychopharmacology 1, 179–203.
4. Carlsson ML (1993) Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis). Journal of Neural Transmission (General Section)9, 1–10.
5. Carlsson M and Carlsson A (1989a) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. Journal of Neural Transmission IS, 221–226.
6. Carlsson M and Carlsson A (1989b) Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine. Journal of Neural Transmission (P-D Section) 1, 317–322.
7. Carlsson M and Carlsson A (1989c) Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. Journal of Neural Transmission (General Section) 77, 65–71.
8. Carlsson M and Carlsson A (1990a) Interactions between glutamatergic and mono-aminergic systems within the basal ganglia: implications for schizophrenia and Parkinson’s disease. Trends in Neuroscience 13, 272–276.
9. Carlsson M and Carlsson A (1990b) Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophrenia Bulletin 16, 425–432.
10. Carlsson M and Svensson A (1990a) Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems. Pharmacology, Biochemistry and Behavior 3, 45–50.
11. Carlsson M and Svensson A (1990b) The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice. Life Science 47, 1729–1736.
12. Carlsson M, Svensson A and Carlsson A (1991) Synergistic interactions between muscarinic antagonists and NMDA antagonists wíth respect to locomotor stimulatory effects in monoamine-depleted mice. Naunyn-Schmiedeberg's Archives of Pharmacology 343, 568–573.
13. Carlsson ML, Engberg G and Carlsson A (1994) Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidíne in monoamine-depleted mice. Journal of Neural Transmission (General Section) 95, 223–233.
14. Clineschmidt BV, Martin GE, Bunting PR and Papp NL (1982) Central sympathomimetic activity of (+)-5-methyl-10, l 1- dihydro(a, d)cyclo-hepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Development and Research 2, 135–145.
15. Domino E and Luby ED (1973) Abnormal mental states induced by phencyclidine as a model of schizophrenia. In: Psychopathology and Psychopharmacology (Eds JO Cole, AM Freedman and AJ Friedhoff). The Johns Hopkins University Press, Baltimore, pp. 37–50.
16. Gellman RL and Aghajanian GK (1991) IPSPs in pyramidal cells in piriform cortex evoked by monoamine excitation of intemeurons demonstrate a convergence of inputs. Society of Neuroscience Abstracts 17, 1:989.
17. Gerfen CR, Engber TM, Mahan LC et al. (1990) D3 and D2 dopamine receptor-regulated gene expression of striatoni- gral and striatopallidal neurons. Science 250, 1429–1432.
18. Goldman-Rakic PS and Selemon LD (1986) Topography of corticostriatal projections in nonhuman primates and implications for functional parcellation of the neostriatum. In: Cerebral Cortex, Vol. 5 (Eds EG Jones and A Peters). Plenum Publishing Corporation, New York, pp. 447–466.
19. Halpain S, Girault J-A and Greengard P (1990) Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature 343, 369–371.
20. Hansson LO, Waters N, Winblad B, Gottfries C-G and Carlsson A (1994) Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortem brain tissue. Journal of Neural Transmission (General Section)98, 217–235.
21. Heimer L, Alheid GF and Zaborszky L (1985) Basal ganglia. In: The Rat Nervous System, Vol. 1, Forehrain and Midbrain(Ed. G Paxinos), pp. 37–86, Academic Press, New York.
22. Heimer L, de Oimos J, Alhcid GP and Zaborszky L (1991) ‘Perestroika’ in the basal lorebiain: opening the border between neurology and psychiatry. Progress in Drain Research 87, 109–165.
23. Komhuber HH, Komhubcr J, Kim JS and Komhuber ME (1984) Zur bioehemischen Theorie dor Schizophrenic. Nervenarzt 55. 602–606.
24. Lodge D, Aran JA, Church J, Davies SN, Martin D and Zeman S (1987) Excitatory amino acids and phencyclidine drugs. In: Excitatory Amino Acid Transmission (Eds TP Hicks, D Lodge and H McLennan), pp. 83–90, Alan Liss, New York.
25. Martin P, Svensson A, Carlsson A and Carlsson ML (1994) On the roles of D-l vs. D-2 receptors for the hyperactivity response elicited by MK-801. Journal of Neural Transmission (General Section) 95, 113–121.
26. Morelli M and Di Chiara G (1990) MK-801 potentiates dopaminergic D, but reduces D2 responses in the 6-hydrox- ydopamine model of Parkinson's disease. European Journal of Pharmacology 182, 61 1–612.
27. Penney JB and Young AB (1986) Striatal inhomogeneities and basal ganglia function. Movement Disorders 1, 3–15.
28. Starr MS and Starr BS (1993a) Glutamate antagonists modify the motor stimulant actions of D and D2 agonists in reserpine-treated mice in complex ways that are not predictive oftheir interactions with the mixed D1/D2 agonist apomorphine. Journal of Neural Transmission (P-D Section) 6, 215–226.
29. Starr MS and Starr BS (1993b) Facilitation of dopamine D, receptor - but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse. European Journal of Pharmacology 250, 239–246.
30. Stille G (1976) Neurophysiological correlates to antipsychotic effects of drugs. In: Antipsychotic Drugs: Pharmacodynamics and Pharmacokinetics (Eds G Sedvall, B Uvnas and Y Zotterman), pp. 51-62, Pergamon Press, Oxford.
31. Svensson A (1995a) Glutamatergic Neurotransmission in the Basal Ganglia and Psychomotor Functions. Thesis, Gteborg University.
32. Svensson TH (1995b) Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and a:-adrenoceptor antagonism. Journal ofClinical Psychopharmacology 15 (Suppl 1), 11S–18S.
33. Svensson A and Carlsson ML (1992) Injection of the competitive NMDA receptor antagonist AP-5 into the nucleus accumbens of monoamine-depleted mice induces pronounced locomotor stimulation. Neuropharmacology 31, 513–518.
34. Svensson A and Carlsson ML (1995) The muscarine antagonist methscopolamine and the NMDA antagonist AP-5 injected unilaterally into the nucleus accumbens cause mice to rotate in opposite directiones. Journal of Neural Transmission (General Section) 101, 149–157.
35. Svensson A, Pileblad E and Carlsson ML (1991) A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive antagonist D-CP- Pene with regard to dopamine turnover and locomotor-stimulatory properties in mice. Journal of Neural Transmission (General Section) 85, 117–129.
36. Svensson A, Carlsson A and Carlsson ML (1992a) Differential locomotor interactions between dopamíne D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice. Journal of Neural Transmission (General Section) 90, 199–217.
37. Svensson A, Carlsson ML and Carlsson A (1992b) Interaction between glutamatergic and dopaminergic tone in the nucleus accumbens of mice: evidence for a dual glutamatergic function with respect to psychomotor control. Journal of Neural Transmission (General Section) 88, 235–240.
38. Svensson A, Carlsson ML and Carlsson A (1994) Glutamatergic neurons projecting to the nucleus accumbens can affect motor functions in opposite directions depending on the dopaminergic tone. Progress in Neuro-Psychopharmacology and Biological Psychiatry 18, 1203–1218.
39. Svensson A, Carlsson ML and Carlsson A (1995) Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice. Journal of Neural Transmission (General Section) 101, 127–148.
40. Tamminga CA, Crayton JC and Chase TN (1978) Muscimol: GABA agonist therapy in schizophrenia. American Journal of Psychiatry 135, 746–748.
41. Tamminga CA, Thaker GK, Gao X-M et al. (1992) Limbic system abnormalities in schizophrenia and neocortical alterations with deficit syndrome. Archives of General Psychiatry 49, 522–530.
42. Weinberger DR (1988) Schizophrenia and the frontal lobe. Trends in Neuroscience 11, 367–370.